EIM
SRPT icon

Essex Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Essex Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,710
Closed -$942K – 513
2020
Q3 		$942K Hold
6,710
– – 0.13% 229
2020
Q2 		$1.08M Sell
6,710
-3,290
-33% -$448K 0.18% 186
2020
Q1 		$978K Hold
10,000
– – 0.2% 160
2019
Q4 		$1.29M Buy
+10,000
New +$1.01M 0.16% 203
2017
Q1 		– Sell
-11,063
Closed -$303K – 370
2016
Q4 		$303K Buy
+11,063
New +$444K 0.05% 294

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Essex Investment Management's SRPT Position: Q4 2020 in Review

Essex Investment Management sold out of Sarepta Therapeutics (SRPT) in Q4 2020, closing a stake of 6,710 shares — an estimated $942K sold.

Essex Investment Management first reported a position in SRPT in Q4 2016 and held it in 5 quarters. The position peaked at $1.29M in Q4 2019. 455 funds tracked by Wall St. Rank hold SRPT as of Q4 2020.

  • Essex Investment Management reported no remaining Sarepta Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Essex Investment Management sold 6,710 Sarepta Therapeutics shares in Q4 2020, an estimated $942K.
  • Essex Investment Management first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 5 quarters.
  • Essex Investment Management's Sarepta Therapeutics position peaked at $1.29M in Q4 2019.
  • 455 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2020.

Based on Essex Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.